Pfizer eyes potential for co-administration of its new Prevnar 20 and the seasonal flu shot
Pfizer has joined the ranks of drugmakers looking to combine seasonal vaccines, revealing new data on Wednesday suggesting its freshly approved 20-valent pneumococcal vaccine can be administered at the same time as the flu shot in older adults.
When received together in a group of volunteers 65 years and older, responses elicited by Prevnar 20 and the seasonal flu vaccine were non-inferior to those elicited by the vaccines when received a month apart, Pfizer said, pointing to new topline data from a Phase III study. The safety profile of Prevnar was similar when the vaccines were taken together versus apart.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
